{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:47:48Z","timestamp":1791161268884,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/hjh.0b013e32835c44bb","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T13:21:21Z","timestamp":1359638481000},"page":"484-491","source":"Crossref","is-referenced-by-count":10,"title":["Effect modification of aortic atheroma on the prognostic value of heart rate in hypertension"],"prefix":"10.1097","volume":"31","author":[{"given":"Pierre-Yves","family":"Courand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Milon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Gustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Froment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Bricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lantelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210208","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.103.10.1428","article-title":"on behalf of the CIBIS II InvestigatorsHeart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial.","volume":"103","author":"Lechat","year":"2001","journal-title":"Circulation"},{"key":"R2-9-20210208","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure.","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"R3-9-20210208","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (shift): the association between heart rate and outcomes in a randomised placebo-controlled trial.","volume":"376","author":"Bohm","year":"2010","journal-title":"Lancet"},{"key":"R4-9-20210208","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0002-8703(93)90128-V","article-title":"Influence of heart rate on mortality among persons with hypertension: the Framingham Study.","volume":"125","author":"Gillman","year":"1993","journal-title":"Am Heart J"},{"key":"R5-9-20210208","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.HYP.37.5.1256","article-title":"Cardiovascular mortality in hypertensive men according to presence of associated risk factors.","volume":"37","author":"Thomas","year":"2001","journal-title":"Hypertension"},{"key":"R6-9-20210208","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1001\/archinte.162.20.2313","article-title":"Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsPredictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension.","volume":"162","author":"Palatini","year":"2002","journal-title":"Arch Intern Med"},{"key":"R7-9-20210208","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.HYP.33.1.44","article-title":"Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure.","volume":"33","author":"Benetos","year":"1999","journal-title":"Hypertension"},{"key":"R8-9-20210208","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004872-198710000-00009","article-title":"Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.","volume":"5","author":"Wilhelmsen","year":"1987","journal-title":"J Hypertens"},{"key":"R9-9-20210208","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"ASCOT investigatorsPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"R10-9-20210208","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"R11-9-20210208","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/01.HYP.0000151324.05355.1c","article-title":"Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.","volume":"45","author":"Kizer","year":"2005","journal-title":"Hypertension"},{"key":"R12-9-20210208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","article-title":"Medical research council working party.","volume":"291","year":"1985","journal-title":"BMJ"},{"key":"R13-9-20210208","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jacc.2008.06.048","article-title":"Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.","volume":"52","author":"Bangalore","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R14-9-20210208","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","article-title":"Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.","volume":"26","author":"Diaz","year":"2005","journal-title":"Eur Heart J"},{"key":"R15-9-20210208","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/eurheartj\/ehp397","article-title":"CRUSADE investigatorsThe association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative.","volume":"31","author":"Bangalore","year":"2010","journal-title":"Eur Heart J"},{"key":"R16-9-20210208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archopht.1953.00920020122001","article-title":"Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis.","volume":"49","author":"Scheie","year":"1953","journal-title":"AMA Arch Ophthalmol"},{"key":"R17-9-20210208","first-page":"231","article-title":"Signs in the fundus oculi and arterial hypertension: unconventional assessment and significance.","volume":"36","author":"Kagan","year":"1967","journal-title":"Bull World Health Organ"},{"key":"R18-9-20210208","first-page":"134","article-title":"Certification and classification of deaths causes.","volume":"30-","author":"Pavillon","year":"2003","journal-title":"BEH"},{"key":"R19-9-20210208","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study.","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"key":"R20-9-20210208","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/oxfordjournals.aje.a113046","article-title":"Heart rate as a prognostic factor for coronary artery disease and mortality findings in three Chicago Epidemiological Studies.","volume":"112","author":"Dyer","year":"1980","journal-title":"Am J Epidemiol"},{"key":"R21-9-20210208","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"on behalf of the BEAUTIFUL investigatorsHeart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial.","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"R22-9-20210208","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0895-4356(95)00022-V","article-title":"The predictive value of admission heart rate on mortality in patients with acute myocardial infarction.","volume":"48","author":"Disegni","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"R23-9-20210208","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/eurheartj\/ehn123","article-title":"Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SRtrandolapril STudy (INVEST).","volume":"29","author":"Kolloch","year":"2008","journal-title":"Eur Heart J"},{"key":"R24-9-20210208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/HYPERTENSIONAHA.108.113191","article-title":"International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes InvestigatorsPrognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations.","volume":"52","author":"Hansen","year":"2008","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"R25-9-20210208","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00004872-199715011-00001","article-title":"Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics.","volume":"15","author":"Van Zwieten","year":"1997","journal-title":"J Hypertens"},{"key":"R26-9-20210208","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/HYPERTENSIONAHA.108.126615","article-title":"on behalf of the Anglo-Cardiff Collaboration Trial InvestigatorsAortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals.","volume":"53","author":"McEniery","year":"2009","journal-title":"Hypertension"},{"key":"R27-9-20210208","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004872-198902000-00008","article-title":"Pulse pressure and echocardiographic findings in essential hypertension.","volume":"7","author":"Pannier","year":"1989","journal-title":"J Hypertens"},{"key":"R28-9-20210208","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/08037050903047202","article-title":"Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study).","volume":"18","author":"Gerdts","year":"2009","journal-title":"Blood Press"},{"key":"R29-9-20210208","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","article-title":"Peripheral arterial disease: morbidity and mortality implications.","volume":"114","author":"Golomb","year":"2006","journal-title":"Circulation"},{"key":"R30-9-20210208","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/01.CIR.81.3.850","article-title":"Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate.","volume":"81","author":"Nabel","year":"1990","journal-title":"Circulation"},{"key":"R31-9-20210208","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/hc3801.096325","article-title":"Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.","volume":"104","author":"Heidland","year":"2001","journal-title":"Circulation"},{"key":"R32-9-20210208","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/hc1002.105135","article-title":"Determinants of accelerated progression of arterial stiffness in normotensive and treated hypertensive subjects over a 6-year period.","volume":"105","author":"Benetos","year":"2002","journal-title":"Circulation"},{"key":"R33-9-20210208","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R34-9-20210208","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjcard.2011.10.025","article-title":"Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.","volume":"109","author":"Julius","year":"2012","journal-title":"Am J Cardiol"},{"key":"R35-9-20210208","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jacc.2009.04.087","article-title":"on behalf of the ASCOT InvestigatorsBaseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).","volume":"54","author":"Poulter","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e32835c44bb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:39:56Z","timestamp":1621885196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201303000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32835c44bb","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}